Literature DB >> 26014051

Surgical margins and oncologic results after carcinoma of the external auditory canal.

Friedrich Ihler1, Mario Koopmann2, Bernhard G Weiss1, Leif Hendrik Dröge3, Martin Durisin4, Hans Christiansen5, Daniel Weiß2, Martin Canis1, Hendrik A Wolff3.   

Abstract

OBJECTIVES/HYPOTHESIS: External auditory canal cancer is rare and carries a poor prognosis. To date, only a few studies provide evidence for clinical decision making in multimodal treatment.
METHODS: Retrospective chart review of 36 cases in three tertiary referral centers.
RESULTS: Thirteen patients were treated by surgery alone, 18 by surgery with adjuvant chemoradiotherapy (CRT) and five by primary CRT. Clear surgical margins (R0) were obtained in 19 patients and positive margins (R1) in 12. The 5-year overall survival and local control rates were 59.4% and 74.2% with R0 status versus 56.6% and 26.3% with R1 status. The 5-year overall survival and local control rates were 46.2% and 70.7% with surgery alone, 78.1% and 43.2% with surgery and adjuvant CRT, and 25.0% and 80.0% with primary CRT.
CONCLUSION: Surgery is integral to the management of external auditory canal cancer, whereas CRT is necessary as an adjuvant or primary treatment, depending on tumor stage. LEVEL OF EVIDENCE: 4.
© 2015 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  Carcinoma; chemoradiotherapy; external auditory canal; retrospective multicenter study; surgical margin; survival rate

Mesh:

Year:  2015        PMID: 26014051     DOI: 10.1002/lary.25381

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Comparison of the University of Pittsburgh staging system and the eighth edition of the American Joint Committee on Cancer TNM classification for the prognostic evaluation of external auditory canal cancer.

Authors:  Shinya Morita; Takatsugu Mizumachi; Yuji Nakamaru; Tomohiro Sakashita; Satoshi Kano; Kimiko Hoshino; Atsushi Fukuda; Keishi Fujiwara; Akihiro Homma
Journal:  Int J Clin Oncol       Date:  2018-07-05       Impact factor: 3.402

2.  Treatment and Outcomes of Carcinoma of the External and Middle Ear: The Validity of En Bloc Resection for Advanced Tumor.

Authors:  Takuma Matoba; Nobuhiro Hanai; Hidenori Suzuki; Daisuke Nishikawa; Eiji Tachibana; Takeshi Okada; Shingo Murakami; Yasuhisa Hasegawa
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-11-15       Impact factor: 1.742

3.  Evaluation of subclasses for T4-classified squamous cell carcinoma of the external auditory canal.

Authors:  Cindy H Nabuurs; Wietske Kievit; C René Leemans; Conrad F G M Smit; Michiel W M van den Brekel; Robert J Pauw; Bernard F A M van der Laan; Jeroen C Jansen; Martin Lacko; Weibel W Braunius; Chunfu Dai; Xunbei Shi; Giovanni Danesi; Jan Bouček; Robert P Takes; Henricus P M Kunst
Journal:  Head Neck       Date:  2022-05-13       Impact factor: 3.821

4.  Evidence Based Tailored Parotidectomy in Treating External Auditory Canal Carcinoma.

Authors:  Jeon Mi Lee; Jin Woo Joo; Sung Huhn Kim; Jae Young Choi; In Seok Moon
Journal:  Sci Rep       Date:  2018-08-14       Impact factor: 4.379

5.  Prognostic Factors Affecting Surgical Outcomes in Squamous Cell Carcinoma of External Auditory Canal.

Authors:  Gi-Sung Nam; In Seok Moon; Ji Hyung Kim; Sung Huhn Kim; Jae Young Choi; Eun Jin Son
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-05-22       Impact factor: 3.372

6.  Evaluation of the modified Pittsburgh classification for predicting the disease-free survival outcome of squamous cell carcinoma of the external auditory canal.

Authors:  Cindy H Nabuurs; Wietske Kievit; Nilou Labbé; C René Leemans; Conrad F G M Smit; Michiel W M van den Brekel; Robert J Pauw; Bernard F A M van der Laan; Jeroen C Jansen; Martin Lacko; Weibel W Braunius; Shinya Morita; Małgorzata Wierzbicka; Takuma Matoba; Nobuhiro Hanai; Robert P Takes; Henricus P M Kunst
Journal:  Head Neck       Date:  2020-08-13       Impact factor: 3.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.